Literature DB >> 20207535

GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.

Konstantinos P Economopoulos1, Theodoros N Sergentanis.   

Abstract

Glutathione S-transferases (GSTs) catalyse reactions between glutathione and lipophilic compounds with electrophilic centres, leading to neutralisation of toxic compounds, xenobiotics and products of oxidative stress. Controversy exists about whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, GSTP1 Ile105Val and GSTA1 *A/*B) represent risk factors for colorectal cancer. This meta-analysis aims to examine the associations between the above-mentioned polymorphisms and colorectal cancer risk. Forty-four studies were eligible for GSTM1 (11,998 colorectal cancer cases, 17,552 controls), 34 studies for GSTT1 (8596 cases, 13,589 controls), 19 studies for GSTP1 (5421 cases, 7671 controls) and four studies for GSTA1 polymorphism (1648 cases, 2039 controls). Pooled odds ratios (ORs) were appropriately derived from fixed-effects or random-effects models. Separate analyses were conducted on Caucasian and Chinese populations. Where appropriate, sensitivity analysis concerning the deviation of genotype frequencies in controls from the Hardy-Weinberg equilibrium was performed. GSTM1 null allele carriers exhibited increased colorectal cancer risk in Caucasian populations (pooled OR=1.150, 95% confidence interval (CI): 1.060-1.248, random effects); no significant association was detected for Chinese subjects (pooled OR=1.025, 95% CI: 0.903-1.163, fixed effects). Similarly, GSTT1 null allele carriers exhibited increased colorectal cancer risk in Caucasian populations (pooled OR=1.312, 95% CI: 1.119-1.538, random effects); the association in Chinese subjects was not significant (pooled OR=1.068, 95% CI: 0.788-1.449, random effects). Concerning GSTP1 Ile105Val no significant associations were demonstrated in either race. GSTA1 *A/*B polymorphism was not associated with colorectal cancer risk. GSTM1 and GSTT1 null genotypes confer additional risk for colorectal cancer in Caucasian populations. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207535     DOI: 10.1016/j.ejca.2010.02.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  54 in total

1.  GSTM1 and GSTT1 polymorphisms and colorectal cancer risk in Chinese population: a meta-analysis.

Authors:  Dan Wang; Li-Mei Zhang; Jun-Xia Zhai; Dian-Wu Liu
Journal:  Int J Colorectal Dis       Date:  2012-01-13       Impact factor: 2.571

2.  Glutathione S-transferase, catalase, and mitochondrial superoxide dismutase gene polymorphisms modulate redox potential in systemic lupus erythematosus patients from Manaus, Amazonas, Brazil.

Authors:  Marco Aurélio Almeida de Oliveira; Neila Hiraishi Mallmann; Giselle Katiane Bonfim Bacellar de Souza; Thiago de Jesus Bacha; Emerson Silva Lima; Domingos Sávio Nunes de Lima; Luiz Fernando de Souza Passos; Marilda de Souza Gonçalves; José Pereira de Moura Neto
Journal:  Clin Rheumatol       Date:  2021-03-20       Impact factor: 2.980

3.  Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk.

Authors:  Monika Eichholzer; Sabine Rohrmann; Aline Barbir; Silke Hermann; Birgit Teucher; Rudolf Kaaks; Jakob Linseisen
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

4.  Serum vitamin C and other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 and GSTT1.

Authors:  Gladys Block; Nishat Shaikh; Christopher D Jensen; Vitaly Volberg; Nina Holland
Journal:  Am J Clin Nutr       Date:  2011-08-03       Impact factor: 7.045

5.  Ethnic differences in the association of the glutathione S-transferase T1 (GSTT1) null genotype and risk of gastric carcinoma: a systematic review and meta-analysis.

Authors:  Jeongmin Yoon; Myung-Han Hyun; Jong-Pill Yang; Min-Jeong Park; Sungsoo Park
Journal:  Mol Biol Rep       Date:  2014-02-22       Impact factor: 2.316

6.  The Variations of Metabolic Detoxification Enzymes Lead to Recurrent Miscarriage and Their Diagnosis Strategy.

Authors:  Chunlan Song; Wei Shang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Associations analysis of GSTM1, T1 and P1 Ile105Val polymorphisms with carpal tunnel syndrome.

Authors:  Pınar Eroğlu; Esra Erkol İnal; Şebnem Özemri Sağ; Özlem Görükmez; Ali Topak; Tahsin Yakut
Journal:  Clin Rheumatol       Date:  2015-01-09       Impact factor: 2.980

8.  Glutathione S-transferase polymorphisms, asthma susceptibility and confounding variables: a meta-analysis.

Authors:  Sara Piacentini; Renato Polimanti; Ilaria Simonelli; Silvia Donno; Patrizio Pasqualetti; Dario Manfellotto; Maria Fuciarelli
Journal:  Mol Biol Rep       Date:  2013-01-10       Impact factor: 2.316

9.  Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.

Authors:  Camila M Lopes-Ramos; Marieke L Kuijjer; Shuji Ogino; Charles S Fuchs; Dawn L DeMeo; Kimberly Glass; John Quackenbush
Journal:  Cancer Res       Date:  2018-10-01       Impact factor: 12.701

10.  Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK).

Authors:  Jamison Chang; Jennie Z Ma; Qing Zeng; Sylvia Cechova; Adam Gantz; Caroline Nievergelt; Daniel O'Connor; Michael Lipkowitz; Thu H Le
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.